Pharma CBD SPAC LENUS

THE STRATEGY OF LENUS BIOSCIENCE SPAC

CREATE VALUE
LENUS ACQUISITIONS SPAC targets to acquire companies in the area of medical cannabis (R&D, pharmaceutical production, distribution of pharmaceutical products that create synergies and bring new technologies and a new approach in their business combination together.

BIOTECH, NANOTECH AND MEDICAL CBD/THC
We believe, that each of these three areas holds significant growth potential and that our team will indeed succeed building a company that combines those areas.

PROVEN EXPERTS
Experts from the financial business and the biotech industry will together evaluate companies to acquire at least 200% to 400% of the IPO proceeds in enterprise value.

GLOBAL CONSENSUS ON GROWTH POTENTIAL
Expecting medical cannabis having a share of one-third of the gross market of legal cannabis and legal cannabis hitting $61 billion, this would result in a $20 billion market for medical cannabis worldwide.

New Frontier Data bases these projections on the markets that have already passed such legal initiatives and don’t include additional states that could come on board in 2019, e.g. Texas and Wisconsin neither, that regarding legalization in the European Union or elsewhere in the world.

With a budget of $1.3 trillion in health care spending, European government-subsidized health care systems will bring the medical cannabis market to dominate Europe and become the largest medical marijuana market in the world.

Germany is poised to be the leader of the European cannabis market, and Italy is expected to be second with $1.2 billion in sales by 2027; Cyprus may produce €235m worth of medicinal cannabis every year.

LENUS ACQUISITIONS SPAC will be filed with S.E.C. during November 2020.

SPAC Consultants: Our holistic approach to SPACs

As experienced SPAC consultants or SPAC advisors, we provide our SPAC advisory and project management services to different group of clients related to SPACs.

Our SPAC consulting and project management services are tailor-made for private equity investors who wish to invest in their own SPAC on the pre-IPO stage as so-called SPAC Sponsors, or who prefer to sponsor an existing SPAC project at its pre-IPO stage.

As SPAC consultants, we are designing and structuring SPACs, arranging for S.E.C. approval and listing at Nasdaq or NYSE, organising pre-IPO roadshows, arrange for IPOs and assist in finding acquisition targets as per a SPAC’s acquisition strategy. Our SPAC consultants and advisers are well experienced on all stages and aspects of SPACs.

If you are interested in setting up a SPAC or in participating in an existing SPAC on its pre-IPO stage, we will be happy to arrange an initial Zoom conference to get acquainted, to further elaborate on SPACs and their manifold opportunities, and to discuss with you your SPAC investment and business ideas.

Important note:
SPAC Consultants is not offering and/or providing investment advisory services in the sense of regulated investment advisory services as per respective EU Directives and their implementation into national law of EU Member States. Instead, SPAC Consultants offers SPAC Project Management services and consults regarding the general principles of US SPACs and their business structuring. Any investment, legal and financial advice that may become necessary for possible sponsors and investors at advanced stages will be provided by the network partners of SPAC Consultants.